Bacterial cells/environment

Bacterial cells/environment is a broad descriptor encompassing prokaryotic organisms and their surrounding ecological niches, such as biofilms, rather than a specific molecular target. In therapeutic development, drugs are designed to hit specific bacterial components—such as ribosomes, penicillin-binding proteins, or DNA gyrase—to achieve selective toxicity against the pathogen while sparing the host (StatPearls, 2023). The 'environment' aspect typically refers to the physiological conditions at the infection site, including pH gradients and the extracellular matrix of biofilms, which can significantly hinder drug penetration and efficacy (Nature Reviews Microbiology, 2018). While the term is often used colloquially to describe the focus of antibacterial therapy, it lacks the specificity required for molecular pharmacology, as it aggregates thousands of potential protein targets and diverse species. Consequently, this entry is classified as incorrect for use in structured drug-target databases, which require specific gene or protein identifiers to accurately map mechanisms of action.

Other names

BacteriaBacterial pathogenMicrobial environmentProkaryotic cellBacterial biofilm

Antibacterial agents act by disrupting essential cellular processes within the bacterial cell, including the inhibition of cell wall synthesis (beta-lactams, glycopeptides), the interference with protein synthesis at the 30S or 50S ribosomal subunits (aminoglycosides, macrolides), and the inhibition of nucleic acid synthesis or repair (fluoroquinolones, rifampin) (NCBI Bookshelf, 2022).